Latest EU News | Page 29

Beyond five-star ratings: The road to decarbonising Commercial Real Estate
Cancer patient navigators improve patient outcomes and reduce healthcare costs
Mike Henry speech at World Mining Congress 2023
Supporting vaccinations and strengthening health systems in 16 African countries
Soliris recommended for approval in the EU by CHMP for children and adolescents with refractory generalised myasthenia gravis (gMG)
ABC Adelaide with Nikolai Beilharz
Statement on migrant deaths from boat capsize enroute to Canary Islands
European regional leaders gather to claim role in international climate processes
Statement on deaths following migrant boat shipwreck off coast of Greece
UN committee dismayed by rising death toll, calls for international cooperation to prioritize safe migration pathways: Greece shipwreck
New guidance published on manufacturer evidence for IVD medical devices
Record Export Revenue for Seafood
Situation of Uyghurs
Massive economic costs of biological invasions
G6 publish joint White Paper
Soliris approved in China for treatment of adults with refractory generalised myasthenia gravis
Innovative technology can help curb child labour in agriculture
Capivasertib in combination with Faslodex granted Priority Review in the US for patients with advanced HR-positive breast cancer
What is the ‘splinternet’? Here’s why the internet is less whole than you might think
European funded research to boost the safety of steel construction products using recycled scrap aluminium
Helena Reichlova leads first Dioscuri Centre in the Czech Republic 
Australian Greens push government to boycott far-right Israeli figures
Climate protection as a human right
Aviation Consumer Protection Regulation Should Address Shared Responsibilities
The European Commission and WHO launch landmark digital health initiative to strengthen global health security
Advancing Australia’s trade interests in Europe
Memory killer cells can improve survival for melanoma patients
How should Australia capitalise on AI while reducing its risks? It’s time to have your say
Travel Demand Continues Strong in April; Domestic Traffic Fully Recovered
Volker Türk in Vienna from 5-8 June for 30th anniversary of landmark declaration that paved way for UN Human Rights Office
Lynparza plus abiraterone approved in the US for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer
Urgent call for action to ensure responsible use of AI
The University of Manchester launches groundbreaking Ukrainian politics course
Agrifood exporter says UK FTA creates fresh opportunities
Ultomiris approved in Japan for the prevention of relapses in patients with neuromyelitis optica spectrum disorder (NMOSD)
Meta just copped a A$1.9bn fine for keeping EU data in the US. But why should users care where data are stored?
Analysis – Key drivers of recent global vegetable oil and cereal price volatility
Study finds 2 billion people will struggle to survive in a warming world – and these parts of Australia are most vulnerable
New method reveals bacterial reaction to antibiotics in five minutes
Wild-caught seafood is often untraceable
7 biggest current issues in Hospitality industry in 2023
Tagrisso plus chemotherapy demonstrated strong improvement in progression-free survival for patients with EGFR-mutated advanced lung cancer in FLAURA2 Phase III trial
There’s a buzz about ‘sustainable’ fuels – but they cannot solve aviation’s colossal climate woes
There’s a buzz about ‘sustainable’ fuels – but they won’t solve aviation’s colossal climate woes
Report: How North West NSW drivers can save $71 million
Allens acts for Livent Corporation on all-stock merger of equals with Allkem to form AU$15.7bn leading global integrated lithium chemicals producer
Security Council: Bosnia and Herzegovina
Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder (NMOSD)